CAS 2278276-46-1

Apitegromab

CAS: 2278276-46-1

Apitegromab (SRK-015) is a new myostatin inhibitor, an antibody targeting myostatin precursor, which can be used to study neuromuscular diseases including

Reinheit: 97.59% (SDS-PAGE); 99.78% (SEC-HPLC) - >95.0% (SDS-PAGE); 99.62% (SEC-HPLC)

Farbe und Form: Liquid

Ref: TM-T77445

Apitegromab

CAS: 2278276-46-1

Apitegromab

Reinheit: ≥95%

Ref: 54-BUP20282